Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 6390-6395, November 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kruszewski, F. H.
Right arrow Articles by DiGiovanni, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kruszewski, F. H.
Right arrow Articles by DiGiovanni, J.

Alterations in Epidermal Polyamine Levels and DNA Synthesis following Topical Treatment with Chrysarobin in SENCAR Mice1

Francis H. Kruszewski2 and John DiGiovanni3

The University of Texas System Cancer Center, Science Park-Research Division, Smithville, Texas 78957

A single topical application of chrysarobin (220 nmol) to SENCAR mouse skin produced alterations in epidermal polyamine levels distinctly different from that following a single topical treatment with 3.4 nmol of 12-O-tetradecanoylphorbol-13-acetate (TPA). Putrescine and spermidine levels were elevated prior to the induction of epidermal ornithine decarboxylase. In this regard, putrescine levels were elevated at 6 and 24 h after a single application of chrysarobin. In addition, putrescine levels were elevated with a second major peak at 64 h after chrysarobin which coincided with elevated epidermal ornithine decarboxylase activity. Spermidine levels were substantially elevated from 24 to 96 h (peak at 60 h) after a single treatment. TPA treatment produced peak elevations in epidermal putrescine levels at 6 h and epidermal spermidine levels at 24 h after a single treatment. Epidermal spermine levels were dramatically depressed following treatment with chrysarobin (peak depression of ~60% below control at 24 h), but only slightly altered following treatment with TPA.

The time courses for changes in epidermal DNA synthesis in mouse skin following single treatments with 3.4 nmol of TPA or 220 nmol of chrysarobin also showed considerable differences. TPA treatment produced several waves of DNA synthesis at approximately 18 and 48 h after treatment, while chrysarobin produced a single broad peak at 72 h after treatment. Treatment with chrysarobin was also associated with an initial, dramatic inhibition in epidermal DNA synthesis (to 23% of the control value) which was much more extensive than that elicited by TPA. Inhibition of epidermal DNA synthesis following treatment with chrysarobin was observed within a few hours after treatment and remained depressed until approximately 36 h after treatment. Following treatment with both chrysarobin and TPA, higher levels of epidermal DNA synthesis correlated closely with higher molar ratios of spermidine/spermine, indicating a strong relationship between epidermal spermidine levels and epidermal cell proliferation induced by both promoters. The data suggest that TPA and chrysarobin bring about initial changes in epidermal polyamines by distinct mechanisms; however, both compounds ultimately lead to a dramatic stimulation of epidermal DNA synthesis. These data further support our working hypothesis that anthrones promote skin tumors by an initial mechanism different from that of the phorbol esters.

1 Research supported by USPHS Grant CA 37111.

2 Recipient of a fellowship from the J. S. Abercrombie Foundation. Present address: National Cancer Institute, NIH, Building 37, Room 3B24, Bethesda, MD 10892.

3 To whom requests for reprints should be addressed.

Received 2/ 2/88. Revised 8/ 8/88. Accepted 8/12/88.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
P. A. Mason, T. J. Walters, J. DiGiovanni, C. W. Beason, J. R. Jauchem, E. J. Dick Jr, K. Mahajan, S. J. Dusch, B. A. Shields, J. H. Merritt, et al.
Lack of effect of 94 GHz radio frequency radiation exposure in an animal model of skin carcinogenesis
Carcinogenesis, October 1, 2001; 22(10): 1701 - 1708.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. DiGiovanni, D. A. Johnston, T. Rupp, L. B. Sasser, L. E. Anderson, J. E. Morris, D. L. Miller, R. Kavet, and E. F. Walborg Jr
Lack of effect of a 60 Hz magnetic field on biomarkers of tumor promotion in the skin of SENCAR mice
Carcinogenesis, April 1, 1999; 20(4): 685 - 689.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.